These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37848421)

  • 1. Single-cell transcriptomic analysis reveals a systemic immune dysregulation in COVID-19-associated pediatric encephalopathy.
    Wang Y; Luu LDW; Liu S; Zhu X; Huang S; Li F; Huang X; Guo L; Zhang J; Ge H; Sun Y; Hui Y; Qu Y; Wang H; Wang X; Na W; Zhou J; Qu D; Tai J
    Signal Transduct Target Ther; 2023 Oct; 8(1):398. PubMed ID: 37848421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas.
    Wang Y; Sun Q; Zhang Y; Li X; Liang Q; Guo R; Zhang L; Han X; Wang J; Shao L; Xue Y; Yang Y; Li H; Nie L; Shi W; Liu Q; Zhang J; Duan H; Huang H; Luu LDW; Tai J; Yang X; Wang G
    J Infect; 2023 May; 86(5):421-438. PubMed ID: 37003521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.
    Ma Y; Qiu F; Deng C; Li J; Huang Y; Wu Z; Zhou Y; Zhang Y; Xiong Y; Yao Y; Zhong Y; Qu J; Su J
    Genome Med; 2022 Feb; 14(1):16. PubMed ID: 35172892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae.
    Wu J; Tang L; Ma Y; Li Y; Zhang D; Li Q; Mei H; Hu Y
    mBio; 2021 Oct; 12(5):e0159921. PubMed ID: 34488453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.
    Li S; Wu B; Ling Y; Guo M; Qin B; Ren X; Wang C; Yang H; Chen L; Liao Y; Liu Y; Peng X; Xu C; Wang Z; Shen Y; Chen J; Liu L; Niu B; Zhu M; Liu L; Li F; Zhu T; Zhu Z; Zhou X; Lu H
    Front Immunol; 2021; 12():625881. PubMed ID: 33717140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4
    Popescu I; Snyder ME; Iasella CJ; Hannan SJ; Koshy R; Burke R; Das A; Brown MJ; Lyons EJ; Lieber SC; Chen X; Sembrat JC; Bhatt P; Deng E; An X; Linstrum K; Kitsios G; Konstantinidis I; Saul M; Kass DJ; Alder JK; Chen BB; Lendermon EA; Kilaru S; Johnson B; Pilewski JM; Kiss JE; Wells AH; Morris A; McVerry BJ; McMahon DK; Triulzi DJ; Chen K; Sanchez PG; McDyer JF
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1403-1418. PubMed ID: 35348444
    [No Abstract]   [Full Text] [Related]  

  • 7. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
    Christensen EE; Jørgensen MJ; Nore KG; Dahl TB; Yang K; Ranheim T; Huse C; Lind A; Nur S; Stiksrud B; Jenum S; Tonby K; Holter JC; Holten AR; Halvorsen B; Dyrhol-Riise AM
    J Intern Med; 2021 Sep; 290(3):677-692. PubMed ID: 34080738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells.
    Hodge G; Barnawi J; Jurisevic C; Moffat D; Holmes M; Reynolds PN; Jersmann H; Hodge S
    Clin Exp Immunol; 2014 Oct; 178(1):79-85. PubMed ID: 24894428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological features of coronavirus disease 2019 in patients with cancer.
    Thibaudin M; Fumet JD; Bon M; Hampe L; Limagne E; Ghiringhelli F
    Eur J Cancer; 2020 Nov; 139():70-80. PubMed ID: 32977223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection.
    Romano A; Parrinello NL; Barchitta M; Manuele R; Puglisi F; Maugeri A; Barbato A; Triolo AM; Giallongo C; Tibullo D; La Ferla L; Botta C; Siragusa S; Iacobello C; Montineri A; Volti GL; Agodi A; Palumbo GA; Di Raimondo F
    Sci Rep; 2022 May; 12(1):7237. PubMed ID: 35508575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.
    Tomić S; Đokić J; Stevanović D; Ilić N; Gruden-Movsesijan A; Dinić M; Radojević D; Bekić M; Mitrović N; Tomašević R; Mikić D; Stojanović D; Čolić M
    Front Immunol; 2021; 12():614599. PubMed ID: 33692788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients.
    Gozzi-Silva SC; Oliveira LM; Alberca RW; Pereira NZ; Yoshikawa FS; Pietrobon AJ; Yendo TM; de Souza Andrade MM; Ramos YAL; Brito CA; Oliveira EA; Beserra DR; Orfali RL; Aoki V; Duarte AJDS; Sato MN
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.
    Hammoudeh SM; Hammoudeh AM; Bhamidimarri PM; Al Safar H; Mahboub B; Künstner A; Busch H; Halwani R; Hamid Q; Rahmani M; Hamoudi R
    Front Immunol; 2021; 12():595150. PubMed ID: 34262555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
    Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H
    J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.
    Zeng X; Jiang X; Yang L; Pan Y; Li Y
    J Immunol Res; 2021; 2021():8669098. PubMed ID: 34712741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles.
    Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL
    PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection.
    Orologas-Stavrou N; Politou M; Rousakis P; Kostopoulos IV; Ntanasis-Stathopoulos I; Jahaj E; Tsiligkeridou E; Gavriatopoulou M; Kastritis E; Kotanidou A; Dimopoulos MA; Tsitsilonis OE; Terpos E
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33375675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Lymphocyte Subsets, PD-1, and FAS (CD95) in COVID-19 Cancer Patients.
    Kandeel EZ; Refaat L; Bayoumi A; Nooh HA; Hammad R; Khafagy M; Abdellateif MS
    Viral Immunol; 2022 Sep; 35(7):491-502. PubMed ID: 35930238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.